AKI Therapeutics A/S — Credit Rating and Financial Key Figures

AKI Therapeutics A/S (CVR number: 37509736) is a company from HØRSHOLM. The company recorded a gross profit of -128.7 kDKK in 2019. The operating profit was -128.7 kDKK, while net earnings were -57.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -15.4 %, which can be considered poor and Return on Equity (ROE) was -13.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -3.8 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. AKI Therapeutics A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.